Michele De Palma
#148,165
Most Influential Person Now
Italian biologist
Michele De Palma's AcademicInfluence.com Rankings
Michele De Palmabiology Degrees
Biology
#13413
World Rank
#16958
Historical Rank
Biotechnology
#268
World Rank
#270
Historical Rank
Molecular Biology
#2451
World Rank
#2489
Historical Rank
Download Badge
Biology
Michele De Palma's Degrees
- Bachelors Biology University of Milan
- Masters Biotechnology University of Milan
Similar Degrees You Can Earn
Why Is Michele De Palma Influential?
(Suggest an Edit or Addition)According to Wikipedia, Michele 'Miki' De Palma is an Italian biologist and a professor at EPFL . He is known for his work on the role of macrophages in cancer progression and the discovery of Tie2-expressing angiogenic monocytes.
Michele De Palma's Published Works
Published Works
- Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. (2005) (1304)
- Microenvironmental regulation of tumour angiogenesis (2017) (1081)
- Macrophage regulation of tumor responses to anticancer therapies. (2013) (909)
- HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. (2011) (641)
- Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells (2003) (602)
- Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. (2011) (573)
- FcRgamma activation regulates inflammation-associated squamous carcinogenesis. (2010) (501)
- Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. (2007) (496)
- Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. (2014) (487)
- Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade (2017) (383)
- Consensus guidelines for the use and interpretation of angiogenesis assays (2018) (370)
- A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. (2009) (352)
- Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. (2015) (331)
- Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models (2018) (316)
- Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. (2010) (310)
- Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis (2011) (293)
- Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. (2007) (277)
- Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. (2004) (273)
- Tie2-expressing monocytes and tumor angiogenesis: regulation by hypoxia and angiopoietin-2. (2007) (255)
- Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. (2008) (254)
- TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. (2011) (220)
- Engineering dendritic cell vaccines to improve cancer immunotherapy (2019) (217)
- The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. (2011) (208)
- Role of angiopoietin-2 in adaptive tumor resistance to VEGF signaling blockade. (2014) (207)
- Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity (2016) (203)
- Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. (2012) (202)
- T cell–induced CSF1 promotes melanoma resistance to PD1 blockade (2018) (199)
- miR-511-3p modulates genetic programs of tumor-associated macrophages. (2012) (194)
- Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. (2010) (192)
- Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion (2011) (190)
- Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. (2005) (174)
- MicroRNA-mediated control of macrophages and its implications for cancer. (2013) (167)
- Macrophage regulation of tumor angiogenesis: implications for cancer therapy. (2011) (166)
- Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors (2005) (158)
- Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. (2010) (155)
- The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities (2012) (143)
- Regulation of Macrophage Arginase Expression and Tumor Growth by the Ron Receptor Tyrosine Kinase (2011) (138)
- Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2. (2015) (136)
- Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity (2018) (129)
- Primary Human and Rat β-Cells Release the Intracellular Autoantigens GAD65, IA-2, and Proinsulin in Exosomes Together With Cytokine-Induced Enhancers of Immunity (2016) (123)
- Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. (2006) (121)
- Cancer: Macrophages limit chemotherapy (2011) (120)
- Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide (2017) (116)
- Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models (2011) (114)
- Perivascular macrophages in health and disease (2018) (112)
- In vivo targeting of tumor endothelial cells by systemic delivery of lentiviral vectors. (2003) (106)
- Tie2-expressing monocytes (TEMs): novel targets and vehicles of anticancer therapy? (2009) (103)
- TIE2-expressing monocytes/macrophages regulate revascularization of the ischemic limb (2013) (98)
- Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease. (2011) (94)
- Angiopoietin-2 TIEs Up Macrophages in Tumor Angiogenesis (2011) (91)
- Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches. (2013) (88)
- Genetic Engineering of Hematopoiesis for Targeted IFN-α Delivery Inhibits Breast Cancer Progression (2014) (87)
- Molecular Profiling and Functional Analysis of Macrophage-Derived Tumor Extracellular Vesicles (2019) (86)
- Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression. (2016) (82)
- Transduction of a gene expression cassette using advanced generation lentiviral vectors. (2002) (81)
- The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors (2017) (76)
- Perivascular Macrophages Limit Permeability (2016) (75)
- Imaging-based spectrometer-less optofluidic biosensors based on dielectric metasurfaces for detecting extracellular vesicles (2021) (66)
- Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy (2019) (53)
- FcR g Activation Regulates Inflammation-Associated Squamous Carcinogenesis (2011) (53)
- Biology and therapeutic targeting of tumour‐associated macrophages (2020) (50)
- PHD2 regulates arteriogenic macrophages through TIE2 signalling (2013) (47)
- Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression. (2018) (47)
- Guidance Molecule SEMA3A Restricts Tumor Growth by Differentially Regulating the Proliferation of Tumor-Associated Macrophages. (2016) (44)
- Reprogramming Tumor Blood Vessels for Enhancing Immunotherapy. (2017) (43)
- EVIR: Chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens (2018) (41)
- TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation (2015) (38)
- CD4+ T Cell Activation and Vascular Normalization: Two Sides of the Same Coin? (2017) (37)
- Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer (2019) (37)
- miR‐135a Inhibits Cancer Stem Cell‐Driven Medulloblastoma Development by Directly Repressing Arhgef6 Expression (2015) (36)
- A new twist on radiation oncology: low-dose irradiation elicits immunostimulatory macrophages that unlock barriers to tumor immunotherapy. (2013) (35)
- Periostin Limits Tumor Response to VEGFA Inhibition. (2018) (34)
- HS1 complexes with cytoskeleton adapters in normal and malignant chronic lymphocytic leukemia B cells (2007) (29)
- miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation (2015) (29)
- Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models (2021) (28)
- Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice. (2020) (26)
- A double agent in cancer: Deciphering macrophage roles in human tumors (2010) (26)
- Partners in crime: VEGF and IL‐4 conscript tumour‐promoting macrophages (2012) (25)
- A role for angiopoietin-2 in organ-specific metastasis. (2013) (25)
- Cellular magnetic resonance with iron oxide nanoparticles: long-term persistence of SPIO signal in the CNS after transplanted cell death. (2014) (23)
- Cancer: Metastasis risk after anti-macrophage therapy (2014) (21)
- developmental relationships embryonic macrophages suggests common functions and Tie 2-expressing monocytes , blood ' ' resident ' ' monocytes , and A distinguishing gene signature shared by tumor-infiltrating (2009) (21)
- miR-511-3 p Modulates Genetic Programs of Tumor-Associated Macrophages (2012) (19)
- Immune Cells and Inflammatory Mediators as Regulators of Tumor Angiogenesis (2008) (18)
- Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan deposition (2021) (18)
- A niche role for periostin and macrophages in glioblastoma (2015) (18)
- The Selective Tie 2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie 2 Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors (2017) (15)
- Disentangling the complexity of tumor-derived extracellular vesicles. (2021) (13)
- Cancer Metastasis: Perivascular Macrophages Under Watch. (2015) (12)
- Origins of Brain Tumor Macrophages. (2016) (11)
- Origins of Brain Tumor Macrophages. (2016) (10)
- TIE2‐expressing monocytes: A novel cellular biomarker for hepatocellular carcinoma? (2013) (9)
- Circulating endothelial progenitors and tumor resistance to vascular-targeting therapies. (2012) (8)
- Sequential Bone-Marrow Cell Delivery of VEGFA/S1P Improves Vascularization and Limits Adverse Cardiac Remodeling After Myocardial Infarction in Mice. (2019) (8)
- Macrophage interference on chemotherapy (2019) (7)
- Regulation by Hypoxia and Angiopoietin-2 Tie 2-Expressing Monocytes and Tumor Angiogenesis : (2007) (6)
- Partners in crime: VEGF and IL‐4 conscript tumour‐promoting macrophages (2012) (5)
- The role of the immune system in cancer: From mechanisms to clinical applications. (2016) (5)
- Taxonomic Revision of Eudicella White (Coleoptera: Cetoniinae) and Iconographic Catalogue (2009) (4)
- Barcoding analysis and taxonomic revision of Goliathus Lamarck, 1802 (Scarabaeidae, Cetoniinae) (2020) (4)
- Dendritic cell cross‐dressing and tumor immunity (2022) (4)
- Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth (2022) (4)
- 2. Promoter Trapping Reveals Significant Differences in Integration Site Selection Between MLV and HIV Vectors (2004) (3)
- Antagonizing metastasis (2010) (3)
- Boosting dendritic cell nanovaccines (2022) (3)
- The role of the immune system in cancer: From mechanisms to clinical applications. (2016) (3)
- MACROPHAGE SKEWING BY PHD 2 HAPLODEFICIENCY PREVENTS ISCHEMIA BY INDUCING ARTERIOGENESIS (2012) (3)
- Tweaking the DNA of myeloid cells curbs cancer spread (2020) (2)
- Author Correction: Perivascular macrophages in health and disease (2021) (2)
- DICERing macrophages for reprogramming TAMs (2016) (2)
- The angiopoietin-Tie2 pathway regulates Purkinje cell dendritic morphogenesis in a cell-autonomous manner (2021) (2)
- Taxonomic Revision of Megalorhina Westwood and subgeneric classification of Mecynorhina Hope (Coleoptera: Cetoniinae) (2010) (2)
- Description of Fornasinius hermes sp. nov. (Coleoptera, Cetoniidae, Goliathini) (2017) (2)
- A LIGHTning Strike to the Metastatic Niche. (2020) (2)
- Abstract 12860: TIE2-Expressing Monocytes/Macrophages Promote Recovery from Tissue Ischaemia (2012) (1)
- Lymphoma Chemotherapy: Hungry Macrophages Strike the Final Blow. (2019) (1)
- Functions Monocytes and Augments Their Inherent Proangiogenic Angiopoietin-2 Regulates Gene Expression in TIE 2-Expressing (2010) (1)
- Role of extracellular vesicles in chemotherapy-induced lung metastasis (2020) (1)
- Tumour-associated macrophages (2012) (1)
- Exosomes, microvesicles, and other extracellular vesicles-a Keystone Symposia report. (2023) (1)
- Alzheimer’s drug turns macrophages against cancer (2021) (1)
- 439. Genetic Manipulation of Liver Sinusoidal Endothelial Cells (LSEC) and Repopulation of the Mouse Liver with Transplanted LSEC Has Therapeutic Implications (2006) (0)
- Use of PCR for detecting Border disease virus in ewe's milk. (1998) (0)
- Abstract IA15: Overcoming tumor resistance to VEGF blockade by co-targeting ANG2/TIE2 signaling and macrophages (2015) (0)
- Forced Expression Of Tie2 Enhances The Angiogenic Potential Of Monocytes/Macrophages (2015) (0)
- Micromanaging restenosis by therapeutic inhibition of miR-92a. (2014) (0)
- Taxonomic revision of genus Fornasinius Bertoloni, 1853 with description of new taxa (Scarabaeidae: Cetoniinae) (2018) (0)
- Abstract 11779: Tie2-Expressing Macrophages Induced by PHD2 Haplodeficiency Prevents Ischemic Damage After Limb Ischemia and Myocardial Infarction by Inducing Collateral Artery Growth (2011) (0)
- Defining and targeting tumor-associated macrophages in malignant mesothelioma (2023) (0)
- Consensus guidelines for the use and interpretation of angiogenesis assays (2018) (0)
- Receptor Tyrosine Kinase Expression and Tumor Growth by the Ron Regulation of Macrophage Arginase (2011) (0)
- Promote Regulatory T Cell Expansion Monocytes To Suppress T Cell Activation and To Angiopoietin 2 Stimulates TIE2-Expressing (2011) (0)
- Imaging-based Optofluidic Biosensors Enabled by All-dielectric metasurfaces (2021) (0)
- Description of a new Eudicella daphnis (Buquet) from Eastern Africa (Scarabaeidae, Cetoniinae) (2010) (0)
- Identification of Scarabaeus micans Drury and taxonomic notes on Dicronorhina Hope, with description of a new species (Coleoptera, Scarabaeidae, Cetoniinae) (2011) (0)
- Mo1824 miR-511-3p, Embedded in the Macrophage Mannose Receptor Gene, Contributes to Experimental Colitis (2015) (0)
- Abstract 1366: Inhibition of Tie2+ macrophage infiltration into tumors in combination with CA-4-P therapy may enhance the clinical efficacy of this vascular disrupting agent (2010) (0)
- 446. Tie2 Expression Defines an Integrated System of Cell Types Specifically Involved in Angiogenesis, and Provides a Platform for Targeted Gene Delivery to Tumors (2005) (0)
- Expansionand To Promote Regulatory T Cell Monocytes To Suppress T Cell Activation Angiopoietin 2 Stimulates TIE2-Expressing (2011) (0)
- Abstract SY15-01: Tumor agnostic dendritic cell vaccines (2023) (0)
- Functional Gene Set Analysis Predicts Novel Cellular And Molecular Immune Mediators Of Impaired Diabetic Wound Healing (2017) (0)
- Precision Targeting of Tumor Macrophages with a CD206 Binding Peptide (2017) (0)
- [Gene therapy in oncology: applications to lung cancer]. (1996) (0)
- Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models (2018) (0)
- Perivascular macrophages in health and disease (2018) (0)
- Serological correlation between the strains of feline calicivirus (FCV) isolated in Italy and F9 vaccine strains. (2000) (0)
- Medical and Personal Characteristics Can Predict the Risk of Lung Metastasis. (2023) (0)
- Remarks on the status of Fornasinius insignis ab. funereus Burgeon, 1937 (Coleoptera, Scarabaeidae, Cetoniinae, Goliathini) (2018) (0)
- Macrophage interference on chemotherapy (2019) (0)
- Vascular Modulatory Functions of Macrophages (2014) (0)
- Identification of the Goliath beetles Fornasinius fornasini Bertoloni and Fornasinius hauseri Kraatz (Scarabaeidae: Cetoniinae) (2018) (0)
- Molecular Profiling and Fu nctional Analysis of Macrophage-Derived Tumor Extracellular Vesicles Graphical (2019) (0)
- 41. Ex Vivo Gene Therapy Provides a Unique Therapeutic Benefit and Corrects Metachromatic (MLD) and Globoid (GLD) Leukodystrophy in the Mouse Models (2004) (0)
- Abstract SY27-02: Heterogeneity of tumor-associated macrophages: Implications for antiangiogenic therapy (2010) (0)
- Integrin-Mediated Macrop hage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer Graphical (2019) (0)
- Abstract 75: Determinants of tumor resistance to anti-angiogenic immunotherapy in mouse models of Kras-mutant NSCLC (2021) (0)
- Coexpression Network Analysis Of Time-Course Transcriptional Response During Cutaneous Wound Healing In A Murine Model Of Diabetes (2017) (0)
- BACR/BMS Special Conference ‘‘Tumour Vasculature: New Targets & Therapies’’ 25th/28th June 2006, Cirencester, UK (2006) (0)
- ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required (2010) (0)
- 50PExtracellular vesicle-internalizing receptors (EVIRs) for dendritic cell-based tumor vaccines (2017) (0)
- Targeting LRG1 boosts immunotherapy. (2021) (0)
- Tweaking the DNA of myeloid cells curbs cancer spread (2020) (0)
- O4 Mechanisms of lung cancer hyper-progression promoted by PD-1 immune checkpoint blockade (2020) (0)
- 5 INVITED Role of haematopoietic cells in tumour angiogenesis: from discovery to targeted cancer gene therapy (2007) (0)
- Giulia Escobar Inhibits Breast Cancer Progression Delivery α Genetic Engineering of Hematopoiesis for Targeted IFN - (2013) (0)
- Abstract IA15: Vascular reprogramming for enhancing cancer immunotherapy (2020) (0)
- Dual Angiopoietin-2/VEGFA Inhibition Elicits Anti-Tumor Immunity That is Enhanced by PD1 Blockade (2017) (0)
- Cancer esearch cular and Cellular Pathobiology ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required R Gliomagenesis (2010) (0)
- Macrophage-derived Vascular Endothelial Growth Factor C re-directs hematogenous metastatic dissemination by normalizing the tumor vasculature (2017) (0)
- Explorer Stimulation of Tumor Relapse After Chemotherapy by Perivascular , Alternatively Activated Macrophages (2015) (0)
- Abstract 2849: Tie2-expressing macrophages (TEM) depletion may enhance the clinical efficacy of combretastatin A-4-phosphate (CA-4-P) (2011) (0)
- TIE2-expressing monocytes regulate revascularisation of the ischaemic limb (2013) (0)
- Macrophage reprogramming for anticancer therapy (2016) (0)
- Assessing metastasis risk after pre-operative anti-angiogenic therapy (2014) (0)
- Monocyte/Macrophage Lineage Cells Significantly Influence The Survival And Proliferation Of Chronic Lymphocytic Leukemia (Cll) Cells (2014) (0)
- All-dielectric Metasurfaces Enabling Imaging-based Real-time Biosensing (2021) (0)
- Abstract A48: Interactions between lymphatic vessels and cancer-associated fibroblasts in tumor immunity (2016) (0)
This paper list is powered by the following services:
Other Resources About Michele De Palma
What Schools Are Affiliated With Michele De Palma?
Michele De Palma is affiliated with the following schools: